This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the Johns Hopkins University School of Medicine. The Johns Hopkins University School of Medicine is accredited by the ACCME to provide continuing medical education for physicians.
Podcast: The Johns Hopkins University School of Medicine designates this enduring material for a maximum of 2.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Estimated Time to Complete Activity: 30 minutes per podcast
This activity has been developed for ophthalmologists and retina specialists.
There are no fees or prerequisites for this activity.
Podcast: The estimated time to complete this activity is 30 minutes.
The eOphthalmology Review series has been developed for clinicians to address key practice and knowledge gaps in managing - Diabetic Retinopathy, Diabetic Macular Edema, Geographic Atrophy, Macular Degeneration, Multimodal Imaging, Myopic CNV and RVO.
Four 30-minute podcast will begin with the "10 Takeaways" from national conference, i.e. ARVO, MSAM, ASRS and APVRS will provide in-depth expert analysis via discussion between the eOphthalmology Review Program Director and key presenters. Email notification to eOphthalmology Review subscribers of the availability of each audio program will contain a link to a website that also contains a "10 Takeaways" (non-accredited) activity, authored by the Program Director, providing synopsis of the other information presented at the conference. The activities are delivered as 4 podcasts, scheduled to be launched shortly after each major ophthalmology conference. Participants will have up to 2 years to complete 4 podcasts in order to earn CME credit.
Date of release: June 29, 2017
Expiration date: June 28, 2019
Estimated time to complete each activity: 30 minutes per podcast
After participating in this activity, the participant will demonstrate the ability to:
- Discuss innovations in retina imaging, such as OCT and FAF, used to diagnose and treat retinal disease.
- Describe how early diagnosis and treatment of AMD improves clinical outcomes.
- Identify patients for appropriate anti-VEFG treatments based on available therapies and the latest data.
- Differentiate between available anti-VEGF agents for diabetic macular edema.
- Evaluate how recent clinical research into anti-VEGF agents informs treatment for proliferative diabetic retinopathy.
- Explain how recent research advances may alter the treatment of retinal vein occlusion.
- Describe how emerging therapies targeting non-neovascular AMD may affect the current landscape of the disease.
- Describe research and developments in the identification and treatment of Myopic Choroidal Neovascularization (MCNV).
As a provider approved by the Accreditation Council for Continuing Medical Education (ACCME), it is the policy of the Johns Hopkins University School of Medicine Office of Continuing Medical Education (OCME) to require signed disclosure of the existence of financial relationships with industry from any individual in a position to control the content of a CME activity sponsored by OCME. Members of the Planning Committee are required to disclose all relationships regardless of their relevance to the content of the activity. Faculty are required to disclose only those relationships that are relevant to their specific presentation. The following relationships have been reported for this activity:
Dr. Neil Bressler, discloses that he has served as a principal investigator for grants to Johns Hopkins University School of Medicine from Bayer Corporation, Novartis AG, Regeneron, Roche, and Samsung.
No other planners have indicated that they have any financial interest or relationships with a commercial entity.
Note: Grants to investigators at The Johns Hopkins University are negotiated and administered by the institution which receives the grants, typically through the Office of Research Administration. Individual investigators who participate in the sponsored project(s) are not directly compensated by the sponsor, but may receive salary or other support from the institution to support their effort on the project(s).
The opinions and recommendations expressed by faculty and other experts whose input is included in this program are their own. This enduring material is produced for educational purposes only. Use of Johns Hopkins University School of Medicine name implies review of educational format design and approach. Please review the complete prescribing information of specific drugs or combination of drugs, including indications, contraindications, warnings and adverse effects before administering pharmacologic therapy to patients.
Based on a review of the current literature, including national and regional measures, detailed conversations with expert educators at Johns Hopkins, and a survey of potential program participants, this program will address the following core patient care gaps:
- Many ophthalmologists remain unaware of advances in imaging technology and operative procedures that are revolutionizing the diagnosis and management of ocular and orbital disease.
- Clinicians require additional data concerning recent advances in age-related macular degeneration (AMD) diagnosis and treatment efficacy as well as safety to provide optimum care to their patients.
- Clinicians need up-to-date guidance on intravitreous anti-VEGF agents, including treatment regimens for diabetic macular edema and proliferative diabetic retinopathy.
- Clinicians are uncertain about whether to wait or promptly treat macular edema from retinal vein occlusions given recent clinical trial results.
- Clinicians may not optimally manage patients with geographic atrophy of the retinal pigment epithelium in age-related macular degeneration due to lack of familiarity with emerging evidence describing the pathophysiology and treatment of the disease.
- Clinicians identification and management of Myopic Choroidal Neovascularization (MCNV) is not adequate to provide optimal patient care.
To receive credit, participants must (1) read the learning objectives and disclosure statements, (2) complete the educational activity, and (3) complete the post-test and activity evaluation form, including the certificate information section. Physicians must attest to the amount of time they spent on the activity.
A passing grade of 70% or higher on the post-test/evaluation is required to receive CE credit.
The Johns Hopkins University School of Medicine takes responsibility for the content, quality and scientific integrity of this CME activity.
I certify that I am attending a Johns Hopkins University School of Medicine CME activity for accredited training and/or educational purposes.
I understand that while I am attending in this capacity, I may be exposed to "protected health information," as that term is defined and used in Hopkins policies and in the federal HIPAA privacy regulations (the "Privacy Regulations"). Protected health information is information about a person's health or treatment that identifies the person.
I pledge and agree to use and disclose any of this protected health information only for the training and/or educational purposes of my visit and to keep the information confidential. I agree not to post or discuss this protected health information, including pictures and/or videos, on any social media site (e.g. Facebook, Twitter, etc.), in any electronic messaging program or through any portable electronic device.
I understand that I may direct to the Johns Hopkins Privacy Officer any questions I have about my obligations under this Confidentiality Pledge or under any of the Hopkins policies and procedures and applicable laws and regulations related to confidentiality. The contact information is: Johns Hopkins Privacy Officer, telephone: 410-735-6509, HIPAA@jhmi.edu
"The Office of Continuing Medical Education at the Johns Hopkins University School of Medicine, as provider of this activity, has relayed information with the CME attendees/participants and certifies that the visitor is attending for training, education and/or observation purposes only."
For CME Questions, please contact the CME Office (410) 955-2959 or e-mail email@example.com. For CME Certificates, please call (410) 502-9634.
Johns Hopkins University School of Medicine Office of Continuing Medical Education Turner 20/720 Rutland Avenue Baltimore, Maryland 21205-2195
Reviewed & Approved by:
General Counsel, Johns Hopkins Medicine (4/1/03)
(Updated 4/09 and 3/14)
The Office of Continuing Medical Education (CME) at the Johns Hopkins University School of Medicine is committed to protecting the privacy of its members and customers. The Johns Hopkins University SOM CME maintains its Internet site as an information resource and service for physicians, other health professionals and the public.
Continuing Medical Education at the Johns Hopkins University School of Medicine will keep your personal and credit information confidential when you participate in a CME Internet-based program. Your information will never be given to anyone outside the Johns Hopkins University School of Medicine's CME program. CME collects only the information necessary to provide you with the services that you request.
To participate in additional CME activities presented by the Johns Hopkins University School of Medicine Continuing Medical Education Office, please visit www.hopkinscme.cloud-cme.com.
To access activities, users will need:
PC: Internet Explorer (v9 or greater), Chrome or Firefox
Monitor settings: High color at 800 x 600 pixels, Sound card and speakers, Adobe Acrobat Reader
Copyright ©2017. JHUSOM and eOphthalmology Review | Presented by JHUSOM in collaboration with DKBmed.